Skip to main content
Penumbra Inc logo

Penumbra Inc — Investor Relations & Filings

Ticker · PEN ISIN · US70975L1070 LEI · 549300RGE06P3ECANU72 US Manufacturing
Open in API
Filings indexed 922 across all filing types
Latest filing 2018-07-02 Interim / Quarterly Rep…
Country US United States of America
Listing US PEN

About Penumbra Inc

https://www.penumbrainc.com/

Penumbra Inc. is a global healthcare company that designs, develops, manufactures, and markets innovative medical devices. The company specializes in interventional therapies for challenging medical conditions within the neurovascular and peripheral vascular markets. Its product portfolio addresses conditions such as acute ischemic stroke, hemorrhagic stroke, and vascular aneurysms. Key technologies include aspiration systems for the revascularization of patients with acute ischemic stroke (e.g., the PENUMBRA SYSTEM) and embolization coil systems for vessel occlusion (e.g., the Swift Coil System). The company focuses on creating novel technologies to improve patient outcomes.

Recent filings

Filing Released Lang Actions
10-Q/A
Interim / Quarterly Report Q1 2018
2018-07-02 English
FORM 4
Director's Dealing
2018-06-27 English
Regulatory Filings 2018
Regulatory Filings Classification · 95% confidence The document is a letter from Penumbra, Inc. to the SEC responding to comments on their previously filed Form 10-K for the fiscal year ended December 31, 2017, and Form 10-Q for the quarterly period ended March 31, 2018. It discusses specific accounting and disclosure issues raised by the SEC staff, including Rule 3-09 of Regulation S-X, fair value measurements, and certifications related to internal control over financial reporting. The letter does not contain the actual financial statements or comprehensive financial data but is a regulatory correspondence addressing SEC comments on filings. Therefore, it is not the Annual Report (10-K) or Quarterly Report (10-Q) itself, but a regulatory filing responding to SEC comments. According to the rules, such correspondence is classified as Regulatory Filings (RNS). The document length (6547 characters) and content confirm it is not a brief announcement or a report publication announcement but a substantive regulatory response letter.
2018-06-21 English
FORM 4
Director's Dealing
2018-06-19 English
Regulatory Filings 2018
Regulatory Filings
2018-06-12 English
8-K
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a Form 8-K current report filed with the SEC, dated June 6, 2018, by Penumbra, Inc. The key content is Item 5.07, which details the submission of matters to a vote of security holders at the company's Annual Meeting held on June 6, 2018. It includes detailed voting results on director elections, auditor ratification, executive compensation advisory vote, and approval of an employee stock purchase plan. This matches the description of Declaration of Voting Results & Voting Rights Announcements (DVA), which covers official results from shareholder votes at any general meeting. The document is not an Annual Report, Proxy Statement, or other report type, but specifically the voting results announcement. The length and content confirm it is not a brief announcement or a report publication notice, but the actual voting results disclosure.
2018-06-08 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.